Related by context. Frequent words. (Click for all words.) 73 Complete Response 72 Complete Response letter 69 Complete Response Letter 67 Approvable Letter 65 Biologics License Application 65 Biologics License Application BLA 64 Marketing Authorization Application 63 Pivotal Phase III 63 Citizen Petition 61 BioDelivery Sciences 61 sNDA 61 Marketing Authorization Application MAA 60 BYDUREON 60 alvimopan 60 prGCD 59 Vilazodone 59 sBLA 59 New Drug Application 59 Act PDUFA date 58 Palatin Technologies Inc. 58 PROMACTA 58 pseudobulbar affect PBA 58 orphan designation 58 NDA submission 58 Phase III Trial 58 ponatinib 58 approvability 58 Scientific Advice 58 Investigational Device Exemption 58 Full Prescribing Information 58 approvable letter 57 Horizant 57 BLA submission 57 QRxPharma 57 Clinical Trial Results 57 Jevtana 57 Phenoptin 57 Rhucin ® 57 Fast Track designation 57 Pirfenidone 57 PREOS 57 Extended Release Tablets 57 Warning Letter 57 PDUFA date 57 eltrombopag 57 Drug Application 57 Pivotal Phase 57 diabetic neuropathic pain 56 L MTP PE 56 iloperidone 56 Cimzia ® 56 Marketing Authorization 56 editor letters@smdailyjournal.com 56 Staff Determination Letter 56 FENTORA 56 Exalgo 56 teduglutide 56 HCV protease inhibitor 56 vandetanib 56 Asentar 56 APF# 56 TORISEL 56 NUVIGIL 56 Phase IIa trial 56 taliglucerase alfa 56 Pivotal Trial 56 Onsolis 56 TREANDA 56 EPIX Pharmaceuticals 56 Icatibant 55 pralatrexate 55 Javelin Pharmaceuticals 55 CoFactor 55 Phase IIa clinical trials 55 CHMP 55 SHPGY 55 velaglucerase alfa 55 BENLYSTA 55 Restanza 55 Cinryze TM 55 LIALDA 55 Phase 1b trial 55 Genasense R oblimersen 55 Strativa 55 investigational compound 55 Staff Deficiency Letter 55 Nasdaq VRTX 55 Amigal 55 Oscient Pharmaceuticals 55 PRX # 55 SILENOR TM 55 Drug Candidate 55 Prescribing Information 55 FDA Approval 55 Oral Suspension 55 Acurox 55 IMPAX Laboratories Inc. 55 lymphoma CTCL 55 Bepreve 55 muraglitazar 55 Orphan Drug Designation